ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
VS-01 shows promise in Phase Ib decompensated liver cirrhosis trial
March 18, 2021The first-in-human trial showed VS-01 is safe and generated improvements in selected biomarkers and clinical cognitive tests in patients with decompensated liver cirrhosis. -
Promethera looks to Asia with €10m investment
January 03, 2019Belgium-based liver disease specialists Promethera Biosciences have received a leg-up for the Asian market in the form of a €10 million investment from Japanese business conglomerate ITOCHU Corporation.
Pharma Sources Insight January 2025
